The Latest Analyst Ratings For Thermo Fisher Scientific
Portfolio Pulse from Benzinga Insights
Thermo Fisher Scientific (NYSE:TMO) has received diverse analyst ratings over the past three months, with a mix of bullish and somewhat bullish sentiments. Analysts have set a 12-month average price target of $632.5, reflecting a 4.7% increase from the previous target. Key financial indicators show strong profitability and effective cost control, despite recent revenue challenges.
June 28, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Thermo Fisher Scientific has received mixed analyst ratings, with a 12-month average price target of $632.5, indicating a 4.7% increase. Despite strong profitability and effective cost control, the company faces revenue challenges.
The mixed analyst ratings and the upward revision of the 12-month price target suggest a positive short-term outlook for TMO. However, the company's recent revenue challenges may temper this optimism. Strong profitability and effective cost control are positive indicators.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100